RecruitingNCT06100328

Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)

Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE): an Investigator-initiated, National, Multicenter, Retrospective-prospective, Cohort Study

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Enrollment

40 participants

Start Date

Oct 26, 2023

Study Type

OBSERVATIONAL

Conditions

Cardiac Tumor

Summary

This study aims to retrospectively and prospectively collect clinical and biological specimen data from patients with cardiac tumors who meet the inclusion and exclusion criteria. Various techniques, including general molecular biology analysis and multi-omics analysis, will be used to construct a prognostic model for cardiac tumors.

Eligibility

Min Age: 3 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cardiac tumor. The study is currently recruiting participants at 1 location. People eligible for this study include aged 3 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

First Affiliated Hospital of Xi'an Jiantong University

Xi'an, Shaanxi, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06100328

Related Trials

Clinical Study of Endocardial Myocardial Biopsy

NCT057181281 location